Welcome to the 23rd Congress in Stockholm, Sweden!

As the premier hematology congress in Europe EHA is going to offer you a congress program covering every subspecialty in hematology and the opportunity to network with experts from all over the globe.

The educational and scientific program will highlight state-of-the art clinical practice, the latest findings in hematology research and many more interesting sessions. The congress also provides you with the opportunity to attend satellite programs, Updates-in-Hematology and to visit the exhibition organized by pharmaceutical companies.

Congress objectives

The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.

Hematologists and affiliated professionals attending the EHA Congress will be able to:

• Enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases.
• Access the latest results on clinical and translational research in hematologic disorders.
• Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties.
• Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.